세계의 로봇 수술 보조기 시장 보고서(2025년)
Robotic Surgical Companion Global Market Report 2025
상품코드 : 1877878
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

로봇 수술 보조기 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 60억 6,000만 달러로 평가되었고, 2025년에는 69억 달러에 달하고, CAGR 14.0%로 성장할 것으로 전망되고 있습니다. 이 성장은 의료용 로봇에 대한 투자 증가, 외과의사에 의한 로봇 지원의 채용 확대, 저침습 수술에 대한 수요 증가, 선진 의료 기술에 대한 의료비 지출 증가, 그리고 수술에 있어서의 정확성과 효율성에 중시의 높아짐 등의 요인에 의한 것으로 보입니다.

로봇 수술 보조기 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 115억 2,000만 달러에 달하고, CAGR은 13.6%를 나타낼 전망입니다. 예측 기간 중 성장 요인으로는 의사 소유의 수술 시설 증가 동향, 복잡한 전문 수술에 있어서의 로봇 기술의 활용 확대, 환자의 저침습 로봇 수술에 대한 인지도와 선호의 높아짐, 클라우드 기반의 수술 데이터 분석의 보급 확대, 수술 실수나 합병증의 최소화에의 주력의 강화 등을 들 수 있습니다. 예측기간의 주요 동향으로는 수술의 정밀도 향상을 위한 인공지능(AI) 및 머신러닝의 통합, 촉각 피드백과 외과의 제어 시스템의 진보, 클라우드 기반의 수술 데이터 관리의 도입, 소형화·유연화된 로봇 기구의 개발 진전, 증강현실(AR) 및 화상 기술의 통합 등을 들 수 있습니다.

암 발생률 증가는 향후 수년간 로봇 수술 보조기 시장의 성장을 견인할 것으로 예측됩니다. 암은 비정상적인 세포가 통제 불능으로 증식하여 주변 조직에 침투하거나 체내의 다른 부위로 전이하거나 하는 질환입니다. 암 증례 증가는 주로 건강에 해로운 생활 습관(부적절한 식단, 운동 부족, 흡연 등)에 기인하며, 이들은 세포 손상 및 비정상적인 증식의 위험을 증가시킵니다. 로봇 수술 보조기는 건강한 조직에 대한 손상을 최소화하고 회복을 가속화하는 고정밀도와 낮은 침습 수술을 가능하게 함으로써 암 치료에 있어 매우 중요한 역할을 합니다. 예를 들어, 2024년 2월 스위스에 본부를 두는 국제기구인 세계보건기구(WHO)는 신규 암 증례 수가 2050년까지 3,500만 건을 넘을 것으로 예측된다고 보고했습니다. 이는 2022년 약 2,000만 건에 비해 77% 증가에 해당합니다. 따라서 암 이환율 증가가 로봇 수술 보조기 시장의 확대에 기여하고 있습니다.

로봇 수술 보조기 시장의 주요 기업은 수술의 정확성 향상, 수술 시간의 단축, 환자 결과의 개선을 도모하기 위해, 특히 AI 탑재 로봇 수술 시스템에 있어서의 기술 혁신을 중시하고 있습니다. AI 탑재 로봇 수술 시스템은 인공지능 알고리즘과 로봇 기구를 조합하여 외과의사가 보다 정확하고 효율적으로 수술 계획의 입안, 유도, 실시를 지원합니다. 예를 들어, 2025년 7월에는 인도의 의료 제공업체인 CARE Hospitals가 정형외과 수술의 정확성을 높이기 위해 Stryker Mako Robotic System을 도입했습니다. 이 첨단 AI 기반 기술은 상세한 3D 모델링과 실시간 로봇 지원을 활용하여 정밀하고 개별화된 관절 대체 수술을 가능하게 합니다. 주요 이점은 수술 정밀도 향상, 조직 손상 감소, 수술 후 통증 감소, 회복 기간 단축, 보다 예측 가능한 치료 결과를 포함합니다. 본 시스템은 정형외과 수술의 질과 일관성 향상을 목표로, 기존의 방법과 비교하여 입원기간 단축과 합병증 감소를 실현하면서 보다 양호한 장기적인 관절기능 유지를 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A robotic surgical companion refers to an advanced robotic system that assists surgeons during surgical procedures by offering precision, improved dexterity, and real-time guidance, which enhances surgical outcomes and minimizes procedural risks. It also simplifies complex surgical tasks, enabling minimally invasive techniques and promoting faster patient recovery.

The main components of robotic surgical companions include hardware, software, and services. Hardware consists of the physical components that form the robotic system, encompassing product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These systems are utilized in various applications, including general surgery, urology, gynecology, orthopedics, cardiovascular surgery, neurosurgery, and others, and are employed by end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The robotic surgical companion market research report is one of a series of new reports from The Business Research Company that provides robotic surgical companion market statistics, including robotic surgical companion industry global market size, regional shares, competitors with a robotic surgical companion market share, detailed robotic surgical companion market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. This robotic surgical companion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic surgical companion market size has grown rapidly in recent years. It will grow from $6.06 billion in 2024 to $6.90 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth during the historic period can be attributed to rising investments in healthcare robotics, increasing surgeon adoption of robotic assistance, growing demand for minimally invasive surgical procedures, higher healthcare spending on advanced medical technologies, and a stronger emphasis on precision and efficiency in surgical operations.

The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth during the forecast period can be attributed to the rising trend of physician-owned surgical facilities, increasing use of robotics in complex and specialty surgeries, growing patient awareness and preference for minimally invasive robotic procedures, expanding adoption of cloud-based surgical data analytics, and a stronger focus on minimizing surgical errors and complications. Key trends in the forecast period include the integration of artificial intelligence and machine learning to enhance surgical precision, advancements in haptic feedback and surgeon control systems, the adoption of cloud-based surgical data management, progress in miniaturized and flexible robotic instruments, and the incorporation of augmented reality and imaging technologies.

The increasing incidence of cancer is expected to drive the growth of the robotic surgical companion market in the coming years. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely attributed to unhealthy lifestyle habits such as poor diet, lack of physical activity, and tobacco use, which heighten the risk of cell damage and abnormal growth. Robotic surgical companions play a crucial role in cancer treatment by enabling highly precise and minimally invasive procedures that minimize damage to healthy tissues and support faster recovery. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of new cancer cases is projected to surpass 35 million by 2050, representing a 77% increase compared to approximately 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the robotic surgical companion market.

Leading companies in the robotic surgical companion market are emphasizing technological advancements, particularly in AI-powered robotic surgery systems, to enhance surgical precision, reduce operating time, and improve patient outcomes. An AI-powered robotic surgery system combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and executing procedures with greater accuracy and efficiency. For example, in July 2025, CARE Hospitals, an India-based healthcare provider, introduced the Stryker Mako Robotic System to improve precision in orthopedic surgeries. This advanced AI-based technology enables highly accurate and personalized joint replacement surgeries using detailed 3D modeling and real-time robotic assistance. Its key advantages include enhanced surgical accuracy, reduced tissue trauma, less postoperative pain, faster recovery, and more predictable outcomes. The system aims to improve the quality and consistency of orthopedic surgeries, supporting better long-term joint function with shorter hospital stays and fewer complications compared to conventional techniques.

In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet's leadership in orthopedic surgery innovation by incorporating Monogram's AI-driven technologies to create the first fully autonomous robotic surgical solutions. The move expands Zimmer Biomet's robotics portfolio and provides surgeons with a more comprehensive and advanced robotic ecosystem to improve surgical outcomes. Monogram Technologies Inc. is a US-based medical device company specializing in robotic surgical companions.

Major players in the robotic surgical companion market are Johnson & Johnson, Siemens Healthineers AG, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, KUKA AG, Globus Medical Inc., Renishaw plc, Meere Company Inc., Asensus Surgical Inc., avateramedical GmbH, Accuray Incorporated, Distalmotion SA, Neocis Inc., Preceyes B.V., Medicaroid Corporation, NDR Medical Technology Pte. Ltd., Robocath SAS, eCential Robotics SAS, and Microbot Medical Inc.

North America was the largest region in the robotic surgical companion market in 2024. The regions covered in robotic surgical companion report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the robotic surgical companion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Robotic Surgical Companion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on robotic surgical companion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for robotic surgical companion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic surgical companion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Robotic Surgical Companion Market Characteristics

3. Robotic Surgical Companion Market Trends And Strategies

4. Robotic Surgical Companion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Robotic Surgical Companion Growth Analysis And Strategic Analysis Framework

6. Robotic Surgical Companion Market Segmentation

7. Robotic Surgical Companion Market Regional And Country Analysis

8. Asia-Pacific Robotic Surgical Companion Market

9. China Robotic Surgical Companion Market

10. India Robotic Surgical Companion Market

11. Japan Robotic Surgical Companion Market

12. Australia Robotic Surgical Companion Market

13. Indonesia Robotic Surgical Companion Market

14. South Korea Robotic Surgical Companion Market

15. Western Europe Robotic Surgical Companion Market

16. UK Robotic Surgical Companion Market

17. Germany Robotic Surgical Companion Market

18. France Robotic Surgical Companion Market

19. Italy Robotic Surgical Companion Market

20. Spain Robotic Surgical Companion Market

21. Eastern Europe Robotic Surgical Companion Market

22. Russia Robotic Surgical Companion Market

23. North America Robotic Surgical Companion Market

24. USA Robotic Surgical Companion Market

25. Canada Robotic Surgical Companion Market

26. South America Robotic Surgical Companion Market

27. Brazil Robotic Surgical Companion Market

28. Middle East Robotic Surgical Companion Market

29. Africa Robotic Surgical Companion Market

30. Robotic Surgical Companion Market Competitive Landscape And Company Profiles

31. Robotic Surgical Companion Market Other Major And Innovative Companies

32. Global Robotic Surgical Companion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Robotic Surgical Companion Market

34. Recent Developments In The Robotic Surgical Companion Market

35. Robotic Surgical Companion Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기